Immunogenicity and Safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14TM) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study

Ramesh V Matur, Subhash Thuluva, Subbareddy Gunneri, Vijay Yerroju, Rammohan reddy Mogulla, Kamal Thammireddy, Piyush Paliwal, Niranjana S Mahantshetty, Mandyam Dhati Ravi, S. Prashanth, Savita Verma, Jai Prakash Narayan
doi: https://doi.org/10.1101/2023.12.21.23300357

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted December 24, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity and Safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14TM) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study
Ramesh V Matur, Subhash Thuluva, Subbareddy Gunneri, Vijay Yerroju, Rammohan reddy Mogulla, Kamal Thammireddy, Piyush Paliwal, Niranjana S Mahantshetty, Mandyam Dhati Ravi, S. Prashanth, Savita Verma, Jai Prakash Narayan
medRxiv 2023.12.21.23300357; doi: https://doi.org/10.1101/2023.12.21.23300357
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area